766 related articles for article (PubMed ID: 22336820)
1. Oral contraceptives containing drospirenone for premenstrual syndrome.
Lopez LM; Kaptein AA; Helmerhorst FM
Cochrane Database Syst Rev; 2012 Feb; (2):CD006586. PubMed ID: 22336820
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives containing drospirenone for premenstrual syndrome.
Lopez LM; Kaptein AA; Helmerhorst FM
Cochrane Database Syst Rev; 2009 Apr; (2):CD006586. PubMed ID: 19370644
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives containing drospirenone for premenstrual syndrome.
Lopez LM; Kaptein A; Helmerhorst FM
Cochrane Database Syst Rev; 2008 Jan; (1):CD006586. PubMed ID: 18254106
[TBL] [Abstract][Full Text] [Related]
4. Oral contraceptives containing drospirenone for premenstrual syndrome.
Ma S; Song SJ
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD006586. PubMed ID: 37365881
[TBL] [Abstract][Full Text] [Related]
5. Combined oral contraceptive pills for treatment of acne.
Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
Cochrane Database Syst Rev; 2012 Jul; (7):CD004425. PubMed ID: 22786490
[TBL] [Abstract][Full Text] [Related]
6. Combined oral contraceptive pills for treatment of acne.
Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
Cochrane Database Syst Rev; 2012 Jun; (6):CD004425. PubMed ID: 22696343
[TBL] [Abstract][Full Text] [Related]
7. Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
Naheed B; Kuiper JH; Uthman OA; O'Mahony F; O'Brien PM
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010503. PubMed ID: 28257559
[TBL] [Abstract][Full Text] [Related]
8. Drospirenone/ethinyl estradiol.
Rapkin AJ; Sorger SN; Winer SA
Drugs Today (Barc); 2008 Feb; 44(2):133-45. PubMed ID: 18389090
[TBL] [Abstract][Full Text] [Related]
9. Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris.
Fenton C; Wellington K; Moen MD; Robinson DM
Drugs; 2007; 67(12):1749-65. PubMed ID: 17683173
[TBL] [Abstract][Full Text] [Related]
10. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
Lopez LM; Grimes DA; Schulz KF
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31711271
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in the treatment of premenstrual dysphoric disorder: a randomized, double blind placebo-controlled study].
Fu Y; Mi W; Li L; Zhang H; Wang J; Cheng W; Sun L; Li L; Xie S; Zhang J
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):506-9. PubMed ID: 25327732
[TBL] [Abstract][Full Text] [Related]
12. Skin patch and vaginal ring versus combined oral contraceptives for contraception.
Lopez LM; Grimes DA; Gallo MF; Stockton LL; Schulz KF
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD003552. PubMed ID: 23633314
[TBL] [Abstract][Full Text] [Related]
13. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice].
Svojanovská K
Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928
[TBL] [Abstract][Full Text] [Related]
14. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
Lopez LM; Grimes DA; Schulz KF
Cochrane Database Syst Rev; 2012 Apr; (4):CD006133. PubMed ID: 22513937
[TBL] [Abstract][Full Text] [Related]
15. Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.
Lopez LM; Grimes DA; Schulz KF
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD006133. PubMed ID: 24788670
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome.
Freeman EW; Halbreich U; Grubb GS; Rapkin AJ; Skouby SO; Smith L; Mirkin S; Constantine GD
Contraception; 2012 May; 85(5):437-45. PubMed ID: 22152588
[TBL] [Abstract][Full Text] [Related]
18. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.
Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD003989. PubMed ID: 23904209
[TBL] [Abstract][Full Text] [Related]
19. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
Lopez LM; Grey TW; Stuebe AM; Chen M; Truitt ST; Gallo MF
Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003988. PubMed ID: 25793657
[TBL] [Abstract][Full Text] [Related]
20. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.
Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
Cochrane Database Syst Rev; 2011 Jan; (1):CD003989. PubMed ID: 21249657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
